Microbot Medical (MBOT) Current Deferred Revenue (2010 - 2025)

Microbot Medical (MBOT) posted Current Deferred Revenue of $93000.0 for Q4 2025, up 452.72% on a QoQ basis from $16826.0 in Q3 2016.

Microbot Medical (MBOT) Current Deferred Revenue (2010 - 2025) Analysis & Trends

Microbot Medical's Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $93000.0 for Q4 2025.

Quarterly Current Deferred Revenue changed N/A year-over-year to $93000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $93000.0 (changed N/A YoY) and the FY2025 annual result came in at $93000.0, changed N/A from the prior year.
Current Deferred Revenue was $93000.0 for Q4 2025 at Microbot Medical, up from $16826.0 in the prior quarter.
Across five years, Current Deferred Revenue topped out at $93000.0 in Q4 2025 and bottomed at $93000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Microbot Medical	27.53 Mn	27.53 Mn	2,000.00

Download Data